Daratumumab

What Daratumumab Means in Everyday Medical Language

Daratumumab is a type of cancer medicine called a monoclonal antibody. It is mainly used to treat multiple myeloma, a cancer that affects plasma cells in the bone marrow. Daratumumab works by targeting a protein called CD38, which is found on the surface of myeloma cells and some immune cells. By binding to CD38, daratumumab helps the immune system recognize and kill cancer cells. It can be given alone or with other cancer drugs, depending on the patient’s situation.

Why Daratumumab Can Matter in Cancer Care

For people with multiple myeloma, daratumumab offers an important treatment option. It is approved for use in adults with newly diagnosed disease, including those who cannot have an autologous stem cell transplant, as well as for patients whose cancer has come back or did not respond to previous treatments. Daratumumab can be combined with other drugs such as dexamethasone, lenalidomide, carfilzomib, or bortezomib to improve treatment effectiveness. It is not a cure but can help control the disease and improve quality of life. Daratumumab is also being studied for other types of cancer, though these uses are still under research.

What Patients Might See or Hear About Daratumumab

Patients may hear the name Darzalex, which is the brand name for daratumumab. There is also a version combined with hyaluronidase called Darzalex Faspro, which can be given as a shorter injection under the skin instead of a longer infusion. Your healthcare team may discuss daratumumab as part of your treatment plan, especially if your multiple myeloma is newly diagnosed or has returned after other treatments. You might see daratumumab mentioned in medical reports, treatment plans, or clinical trial information. It is common to have questions about how it is given, possible side effects, and how it fits with other treatments.

Where Daratumumab May Appear in Your Care

Daratumumab may be listed in your medical records, treatment plans, or drug lists. It might also appear in clinical trial descriptions if you are considering research studies. The drug can be given as an intravenous infusion or as a subcutaneous injection when combined with hyaluronidase. Your care team will explain how it fits into your overall treatment and what to expect during therapy.

What Daratumumab Does Not Automatically Mean

Seeing the word daratumumab does not mean it will be used for every patient with multiple myeloma or that it is a cure. It is one of several treatment options and may not be suitable for everyone. Also, daratumumab’s use outside of multiple myeloma is still being studied and is not part of standard care for other cancers yet. The presence of daratumumab in a report or plan should be discussed with your care team to understand what it means for your specific situation.

Common Questions to Ask Your Care Team

You might want to ask how daratumumab works, what side effects to expect, how it will be given, and how it compares to other treatments. It is also helpful to ask if daratumumab will be combined with other drugs and what the treatment schedule will look like. If you see the name Darzalex or Darzalex Faspro, ask about the differences and what is best for you.

How to Read the Term in Context

Daratumumab may appear in medical records, drug lists, or clinical trial information. It is important to ask your healthcare team what it means in your specific case rather than assuming it applies the same way to everyone. The term may also appear as DAR in some reports, which can cause confusion. Always clarify with your care team to understand how daratumumab fits into your treatment.

Safety and Next Steps

This information is meant to help you understand daratumumab but does not replace medical advice. Only your healthcare team can decide if daratumumab is safe and appropriate for you. If you see this term in your records or hear it mentioned, the best next step is to ask your care team to explain what it means for your treatment and what to expect. They can provide personalized information based on your health and cancer history.